Bioeconomy Capital

3417 Evanston Ave N, Seattle, Washington US
Investor type VC
Founded -
AUM -
Location United States

Profile

Bioeconomy Capital (BeC) invests in early stage companies with the goal of accelerating the biotechnology revolution. Based on our startup operational expertise, product development experience, and globally recognized strategic analysis, we have developed a blueprint for building and deploying technological capabilities that will become critical infrastructure of the 21st century economy. This proprietary blueprint is the distillation of the fund managers'​ five decades of combined experience in synthetic biology and other engineering fields and cannot be readily duplicated. Prior investments include Zymergen, Riffyn, Synthace, RoosterBio, Arzeda, Bellwether Bio, EdenWorks, and Lumen Biosciences

Industry focus

Biotechnology Food and Beverage Marketing and Advertising Software

Investment preferences

Investment Ticket

$1-5 m

Investment Horizon

3-5 years

Investment Stage

Seed

Exit Strategy

Sale to strategic investor

IPO

Region focus

North America

Contacts

Name Title
Name Title email@email.com LinkedIn
Name Title email@email.com LinkedIn
Name Title email@email.com LinkedIn